Xspray Pharma AB (publ) logo

Xspray Pharma AB (publ)

SSE:XSPRAY.ST

Overview | Financials
Company Name Xspray Pharma AB (publ)
Symbol XSPRAY.ST
Currency SEK
Price 44
Market Cap 1,375,154,000
Dividend Yield 0%
52-week-range 28.1 - 83.736
Industry Biotechnology
Sector Healthcare
CEO Dr. Per Andersson Ph.D.
Website https://www.xspraypharma.com

An error occurred while fetching data.

About Xspray Pharma AB (publ)

Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo for the treatment of chronic myeloid leukemia; HyNap-Sora for the treatment of renal cancer and liver cancer, as well as several forms of thyroid cancer; and HyNap-Dasa for

Related Stocks

Senzime AB (publ) logo

Senzime AB (publ)

SEZI.ST

7.25 SEK

ADDvise Group AB (publ) logo

ADDvise Group AB (publ)

ADDV-A.ST

11.6 SEK

Diamyd Medical AB (publ) logo

Diamyd Medical AB (publ)

DMYD-B.ST

13.3 SEK

Cantargia AB (publ) logo

Cantargia AB (publ)

CANTA.ST

3.32 SEK

C-Rad AB (publ) logo

C-Rad AB (publ)

CRAD-B.ST

46.55 SEK

Biovica International AB (publ) logo

Biovica International AB (publ)

BIOVIC-B.ST

2.34 SEK

Paxman AB (publ) logo

Paxman AB (publ)

PAX.ST

38.6 SEK

Isofol Medical AB (publ) logo

Isofol Medical AB (publ)

ISOFOL.ST

0.616 SEK

Infant Bacterial Therapeutics AB (publ) logo

Infant Bacterial Therapeutics AB (publ)

IBT-B.ST

93.4 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD